{"title":"Thromboembolism Prophylaxis after Cesarean Section","authors":"N. Mahmood, K. Sharif","doi":"10.12816/0047457","DOIUrl":null,"url":null,"abstract":"22 The incidence of VTE in pregnancy is ten times higher than the age-matched, non-pregnant population1-3. VTE could occur at any stage of pregnancy, but the risk is higher at the puerperium1,4. VTE continues to be a leading cause of maternal mortality5-7. Pulmonary embolism (PE) is the leading cause of maternal death in the United Kingdom, accounting for approximately 1.8 per 100,000 deliveries and 11% of maternal deaths in the United States5-9. PE is the second leading cause of maternal death in Saudi Arabia, accounting for 25% of all maternal deaths10. In Bahrain, PE is accounting for 35% of all maternal deaths in sickle cell disease (SCD) patients, as well as 21% of non-SCD11,12.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12816/0047457","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
22 The incidence of VTE in pregnancy is ten times higher than the age-matched, non-pregnant population1-3. VTE could occur at any stage of pregnancy, but the risk is higher at the puerperium1,4. VTE continues to be a leading cause of maternal mortality5-7. Pulmonary embolism (PE) is the leading cause of maternal death in the United Kingdom, accounting for approximately 1.8 per 100,000 deliveries and 11% of maternal deaths in the United States5-9. PE is the second leading cause of maternal death in Saudi Arabia, accounting for 25% of all maternal deaths10. In Bahrain, PE is accounting for 35% of all maternal deaths in sickle cell disease (SCD) patients, as well as 21% of non-SCD11,12.